INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
A Review-Labetalol First-line Drug for Pregnancy-induced Hypertension
Authors Name:
prof.Pratibha J.Kale
, Mr.Suhas A.Netke
Unique Id:
IJSDR2007042
Published In:
Volume 5 Issue 7, July-2020
Abstract:
To study labetalol as a first-line drug for hypertension in pregnancy and endorse its superiority over alpha-methyldopa. Patients with diastolic blood pressure recorded 100 mmHg have been admitted and administered labetalol 100 mg twice-daily orally, the dose escalating to 1.2 g/day. The control of pressures and side effects have been noted. Labetalol is instrumental in causing a sustained and smooth fall in blood pressure and is free of the side effects of alpha-methyldopa. Thus, labetalol supercedes alpha-methyldopa as a first-line drug for hypertension in pregnancy.
"A Review-Labetalol First-line Drug for Pregnancy-induced Hypertension", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.5, Issue 7, page no.323 - 324, July-2020, Available :http://www.ijsdr.org/papers/IJSDR2007042.pdf
Downloads:
000337353
Publication Details:
Published Paper ID: IJSDR2007042
Registration ID:192090
Published In: Volume 5 Issue 7, July-2020
DOI (Digital Object Identifier):
Page No: 323 - 324
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn